Article
A Machine Learning Approach to Predict Cognitive Decline in Alzheimer’s Disease Clinical Trials
2024-09-04
Abstract excerpt
<h4>Background</h4> Of persons randomized to the placebo arm of Alzheimer’s Disease (AD) treatment trials, 40% do not show cognitive decline over 80 weeks of follow-up. Identifying and excluding these individuals from both arms of randomized clinical trials (RCTs) of AD has the potential to increase power to detect treatment effects. <h4>Objectives</h4> We aimed to develop machine learning-based predictive model...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- bc2eca2b-6f70-52a9-ab1c-6b02c9371df9
- DOI
- 10.1101/2024.09.03.24312481
